IMO, no merger or sell out is in the near future. I think the suggestions are only conjecture of what would be better than the current situation. IMO, the only assets of value AVBC has is its hydrator formulas and any other product lines developed, and the artwork on Hydrators. I dont know if their antiseptic preservative free process is proprietary, but if they created it, they should have been franchising it for the past several years to fund their Hydrator launches. I could see one of the big boys buying the formulas or in a partnership type arrangement, i.e. commission to AquaVie for each case sold, but why pay more for the company? The big boys would handle the marketing, distribution, production, financing, and everything else. Seems like something they would have pursued after the first NYC launch when they needed production, financing, and distribution. Personally, that is the direction I would have gone, but I do not hold preferred shares, etc. here.
I recall a PR saying AVBC needed $20 million to open its own bottling plants, two in the US I think. I think TG wants the whole enchilada and considers selling or franchising the formulas as taking a back seat.
AVBC is not as successful today as TG expected in the PRs two years ago, but I think he will continue in the same manner until he succeeds in getting it to market or the cash flow runs out - not in the near future.
Obviously they will be in a better position for financing and partnerships if they can boost sales to a profitable level.
AI
Market Data 
Markets 
